Neurocrine Biosciences, Inc. (NASDAQ:NASDAQ:NBIX) Q1 2022 Earnings Conference Call May 04, 2022, 08:00 ET Company Participants Todd Tushla - VP, IR Kevin Gorman - CEO & Director Matthew...

Related Keywords

Japan , United States , Russia , Ukraine , Japanese , American , Todd Tushla , Raymond James , Chris Shibutani , Kyle Gano , Josh Schimmer , Laura Chico , Mandy Parkinson , Joshua Schimmer , Piper Sandler , Matthew Abernethy , Amy Roberts , Phil Nadeau , Eric Benevich , William Blair , Neena Bitritto Garg , Anupam Rama , Charles Duncan , Carter Gould , Marc Goodman , Paul Matteis , Matt Abernethy , Brian Abrahams , Amy Fadata , Jay Olson , Danielle Brill , America Merrill Lynch , Myles Minter , Brian Skorney , Yatin Suneja , Eiry Roberts , David Amsellem , Tazeen Ahmad , Philip Nadeau , Kevin Gorman , Morgan Stanley , Company Participants , Goldman Sachs , Nasdaq , Jpmorgan Chase Co , Cantor Fitzgerald , Nicolaus Company , Goldman Sachs Group , Robertw Baird Co , Barclays , Neurocrine Biosciences Inc , Barclays Bank , Cantor Fitzgerald Co , Mitsubishi Tanabe Pharma Corporation , William Blair Company , American Academy Of Neurology , Huntington Disease Study Group , Citigroup , Business Development , Serco , Neurocrine Biosciences , Conference Call May , America Merrill , Neurocrine Biosciences Reports First Quarter , Chief Executive Officer , Chief Financial Officer , Chief Medical Officer , Chief Commercial Officer , Chief Business Development , Chief Commercial , Tardive Dyskinesia Awareness , Chief Medical , Disease Study Group , American Academy , Unified Huntington , Disease Rating Scale , Total Maximal Chorea Score , What Serco , North America , Total Maximal Chorea , Vamil Divan , Jeff Hung ,